# 医疗领域的开源基础模型：挑战、悖论与机遇，以及生成式AI驱动的个性化处方

发布时间：2025年02月04日

`LLM应用

LLM应用`

> Open Foundation Models in Healthcare: Challenges, Paradoxes, and Opportunities with GenAI Driven Personalized Prescription

# 摘要

> # 摘要  
针对 OpenAI 的 GPT-4 等专有大型语言模型 (LLMs) 的成功，人们日益增长的兴趣在于开发开放、非专有的 LLMs 和 AI 基础模型 (AIFMs)，以便在学术、科学和非商业应用中透明地使用。尽管它们无法匹配专有模型的精细功能，但开源模型在医疗应用领域具有巨大的潜力，能够带来革命性的变革。  
本文探讨了开源 LLMs 和 AIFMs 在开发医疗应用中的前景，并做出了两项关键贡献。首先，我们对当前最先进的开源医疗 LLMs 和 AIFMs 进行了全面的调查，并提出了这些开源 AIFMs 的分类法，分类了它们在各种医疗任务中的实用性。其次，为了评估开源 LLMs 在医疗领域的通用应用，我们展示了一个个性化处方的案例研究。由于该任务在提供量身定制的、患者特异性的药物方面具有关键作用，能够显著改善治疗效果，因此尤其重要。  
此外，我们比较了在有无检索增强生成 (RAG) 的情况下，开源模型与专有模型的性能。我们的研究发现表明，尽管开源 LLMs 的功能不那么精细，但当与 RAG 等 grounding 技术结合使用时，它们可以实现与专有模型相当的性能。此外，为了突出 LLMs 赋能的个性化处方的临床意义，我们通过专家临床医生进行主观评估。我们还详细阐述了与强大 LLMs 和 AIFMs 滥用相关的伦理考虑和潜在风险，强调了在医疗领域谨慎和负责任地实施的必要性。

> In response to the success of proprietary Large Language Models (LLMs) such as OpenAI's GPT-4, there is a growing interest in developing open, non-proprietary LLMs and AI foundation models (AIFMs) for transparent use in academic, scientific, and non-commercial applications. Despite their inability to match the refined functionalities of their proprietary counterparts, open models hold immense potential to revolutionize healthcare applications. In this paper, we examine the prospects of open-source LLMs and AIFMs for developing healthcare applications and make two key contributions. Firstly, we present a comprehensive survey of the current state-of-the-art open-source healthcare LLMs and AIFMs and introduce a taxonomy of these open AIFMs, categorizing their utility across various healthcare tasks. Secondly, to evaluate the general-purpose applications of open LLMs in healthcare, we present a case study on personalized prescriptions. This task is particularly significant due to its critical role in delivering tailored, patient-specific medications that can greatly improve treatment outcomes. In addition, we compare the performance of open-source models with proprietary models in settings with and without Retrieval-Augmented Generation (RAG). Our findings suggest that, although less refined, open LLMs can achieve performance comparable to proprietary models when paired with grounding techniques such as RAG. Furthermore, to highlight the clinical significance of LLMs-empowered personalized prescriptions, we perform subjective assessment through an expert clinician. We also elaborate on ethical considerations and potential risks associated with the misuse of powerful LLMs and AIFMs, highlighting the need for a cautious and responsible implementation in healthcare.

[Arxiv](https://arxiv.org/abs/2502.04356)